TECX Tectonic Therapeutic Inc.
Health Care, filed as TECTONIC THERAPEUTIC INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
- 1 exit
In 2026 Q2 James Silverman sold out of Tectonic Therapeutic.
Who owns TECX
Sorted by value, long equity only, as of 2026 Q2. Exits show their last held size.
| History | |||||
|---|---|---|---|---|---|
| James Silverman, Opaleye Management exited 2026 Q2 Last 2026 Q1 | Exit −0.50% | 123,000 | $3.8M | History |
Insider trades
Open-market buys and sales by TECX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $182K bought by 2 insiders
- None no sales outside a trading plan
- $651K sold by 2 insiders under 10b5-1 plans
-
Peter McNamara Chief Scientific OfficerPlanned sale$12K 536 shares at $23.04 1% of stakeTraded Sep 30 Filed Oct 2
-
Peter McNamara Chief Scientific OfficerPlanned sale$1,570 43 shares at $36.52 0.1% of stakeTraded Aug 25 Filed Aug 26
-
Peter McNamara Chief Scientific OfficerPlanned sale$1,505 43 shares at $35.00 0.1% of stakeTraded Aug 12 Filed Aug 14
-
Peter McNamara Chief Scientific OfficerPlanned sale$6,020 172 shares at $35.00 0.3% of stakeTraded Jun 30 Filed Jul 1
-
Marcella K. Ruddy Chief Medical OfficerPlanned sale$32K 1,065 shares at $30.00 1.5% of stakeTraded May 4 Filed May 6
-
Marcella K. Ruddy Chief Medical OfficerPlanned sale$31K 1,000 shares at $31.05 1.4% of stakeTraded Apr 1 Filed Apr 3
-
Marcella K. Ruddy Chief Medical OfficerPlanned sale$300K 10,000 shares at $30.00 13% of stakeTraded Mar 6 Filed Mar 9
-
Peter McNamara Chief Scientific OfficerPlanned sale$189K 6,262 shares at $30.17 10% of stakeTraded Mar 6 Filed Mar 9
-
Peter McNamara Chief Scientific OfficerPlanned sale$78K 3,299 shares at $23.53 5.3% of stakeTraded Mar 3–4 Filed Mar 5
-
Alise Reicin CEOBuy$53K 2,500 shares at $21.10 +2% to stakeTraded Feb 11 Filed Mar 5
-
Daniel Lochner CFOBuy$130K 6,000 shares at $21.61 +23% to stakeTraded Feb 10 Filed Feb 11
Also filed in the last 12 months, not counted as buying or selling: 11 share withholdings for taxes, 8 option exercises, and 5 stock grants.
Congress
No member of Congress reported trading TECX in the last three years. 1 member listed it in 2025 annual reports.
SEC filings
Recent issuer filings from EDGAR, 9 shown.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $100.26M | $146.86M | $257.36M |
| Total non-current assets * | $0.832M | $6.05M | $3.68M |
| Total assets | $101.09M | $152.9M | $261.04M |
| Total current liabilities | $6.35M | $11.61M | $9.67M |
| Total non-current liabilities * | $0.00 | $519,000 | $43,000 |
| Total equity | $94.74M | $140.78M | $251.33M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.